Bioavailability Enhancement: Determination and Conceptual Approaches in Overcoming Bioavailability Problems
Bioavailability Enhancement: Drug Permeability Enhancement
Drug Products: Biologics, Biosimilars and Interchangeables
Drug Control Governance: Regulatory Bodies and Their Impact
Prescription, Nonprescription and Orphan Drugs
Drug Regulation
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Nov 13, 2025

Author Spotlight: Cost-Effective Transcriptomic Drug Screening - Unlocking New Targets
Published on: February 23, 2024
Robert M Califf1,2, Andrew Slavitt3
1Duke Forge, Duke University School of Medicine, Durham, North Carolina.
No abstract available in PubMed .